WHO Prequalifies Ebola Vaccine To Speed Up Availability In Africa
Local Regulators Ready To Issue Rapid Approvals
Following its recent EU approval, moves are under way to make Merck’s Ervebo vaccine available in countries at risk of Ebola.
You may also be interested in...
Regulators have pulled out all the stops in their efforts to get the Ebola vaccine to the marketing authorization stage in Africa.
As stockpiles of Ebola vaccine are being built up around the world, Médecins sans Frontières has said more action is needed to ensure sufficient numbers of vaccinations are available for use in current and future outbreaks.
Merck Sharp & Dohme will begin manufacturing licensed doses of Ervebo in Germany and will continue to send investigational vaccine doses to Democratic Republic of Congo.